Basics Rockwell Medical, Inc. (DE) Common Stock Rockwell Medical Inc is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism, and hemodialysis. IPO Date: February 1, 1998 Sector: Healthcare Industry: Health Care Equipment and Supplies Market Cap: $40.63M Activated in VL: True Average Daily Range Avg Daily Range: $0.07 | 3.85% Avg Daily Range (30 D): $0.04 | 2.83% Avg Daily Range (90 D): $0.05 | 4.09% Institutional Daily Volume Avg Daily Volume: .62M Avg Daily Volume (30 D): .94M Avg Daily Volume (90 D): 1.02M Trade Size Avg Trade Size (Sh.): 301 Avg Trade Size (Sh.) (30 D): 354 Avg Trade Size (Sh.) (90 D): 316 Institutional Trades Total Inst.Trades: 185 Avg Inst. Trade: $1.17M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.46M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 30.67K     News Aug 14, 2025 @ 10:21 AM Rockwell Medical Tops Q2 EPS View Source: Jesterai Oct 9, 2024 @ 8:12 PM DaVita Stock Gains 47.3% Year to Date: What's Behi... Source: Zacks, Benzinga Contributor May 14, 2024 @ 11:15 AM Rockwell Medical (RMTI) Reports Q1 Loss, Tops Reve... Source: Zacks Equity Research Mar 26, 2024 @ 10:15 PM Rockwell Medical (RMTI) Increases Despite Market S... Source: Zacks Equity Research Mar 21, 2024 @ 11:10 AM Rockwell Medical (RMTI) Q4 Earnings and Revenues B... Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.08 $-.05 $-.04 Diluted EPS $-.09 $-.05 $-.04 Revenue $ 87.97M $ 16.07M $ 18.91M Gross Profit $ 15.42M $ 2.5M $ 3.04M Net Income / Loss $ -2.1M $ -1.49M $ -1.52M Operating Income / Loss $ -1.29M $ -1.35M $ -1.36M Cost of Revenue $ 72.55M $ 13.57M $ 15.87M Net Cash Flow $ .62M $ 1.09M $ -4.27M PE Ratio     Splits May 13, 2022:   1:11